AR and neoplasm: Our work establishes the feasibility in utilizing gene expression microarrays for evaluating AR expression in tumor tissue, and this is one potential platform that could be considered in future trials, as it may circumvent the issue of non-standardization of immunohistochemical assays to identify patients who may benefit from AR blockade.